Anna Varberg Reisæter

  • Head of section Dr. med.
 

Publications 2019

Eide IA, Rashidi F, Lønning K, Oldereid NB, Reisæter AV, Åsberg A, Midtvedt K (2019)
Contraceptive Choices and Counseling in Norwegian Female Renal Transplant Recipients
Transplant Proc, 51 (2), 470-474
DOI 10.1016/j.transproceed.2019.01.068, PubMed 30879570

Gustavsen MT, Midtvedt K, Lønning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Åsberg A (2019)
Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial
Transpl Int (in press)
DOI 10.1111/tri.13412, PubMed 30770608

Haugen AJ, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2019)
Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
Transpl Int (in press)
DOI 10.1111/tri.13443, PubMed 30983060

Mjoen G, Reisæter A, Hartmann A, Dahle DO, Holdaas H (2019)
Regarding age-calibrated glomerular filtration rate
Kidney Int, 95 (1), 234-235
DOI 10.1016/j.kint.2018.10.003, PubMed 30606421

Thorsen IS, Bleskestad IH, Åsberg A, Hartmann A, Skadberg Ø, Brede C, Ueland T, Pasch A, Reisaeter AV, Gøransson LG (2019)
Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study
Clin Transplant, 33 (5), e13517
DOI 10.1111/ctr.13517, PubMed 30844090

Publications 2018

Ceretta ML, Noordzij M, Luxardo R, De Meester J, Abad Diez JM, Finne P, Heaf JG, Couchoud C, Kramar R, Collart F, Cases A, Palsson R, Reisæter AV, Rydell H, Massy ZA, Jager KJ, Kramer A (2018)
Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry
Nephrol Dial Transplant, 33 (10), 1794-1804
DOI 10.1093/ndt/gfx355, PubMed 29361126

Egeland EJ, Reisaeter AV, Robertsen I, Midtvedt K, Strøm EH, Holdaas H, Hartmann A, Åsberg A (2018)
High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study
Transpl Int, 32 (3), 257-269
DOI 10.1111/tri.13356, PubMed 30252957

García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Reisaeter AV, Seron D (2018)
Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation
Clin Transplant, 32 (3), e13196
DOI 10.1111/ctr.13196, PubMed 29380890

Heldal K, Midtvedt K, Hartmann A, Reisaeter AV, Heldal TF, Bergan S, Salvador CL, Åsberg A (2018)
Estimated glomerular filtration rate in stable older kidney transplant recipients-are present algorithms valid? A national cross-sectional cohort study
Transpl Int, 31 (6), 629-638
DOI 10.1111/tri.13137, PubMed 29453878

Heldal TF, Ueland T, Jenssen T, Hartmann A, Reisaeter AV, Aukrust P, Michelsen A, Åsberg A (2018)
Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study
Transpl Int, 31 (5), 510-519
DOI 10.1111/tri.13116, PubMed 29341300

Hruskova Z, Pippias M, Stel VS, Abad-Díez JM, Benítez Sánchez M, Caskey FJ, Collart F, De Meester J, Finne P, Heaf JG, Magaz A, Palsson R, Reisæter AV, Salama AD, Segelmark M, Traynor JP, Massy ZA, Jager KJ, Tesar V (2018)
Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry
Am J Kidney Dis, 73 (2), 184-193
DOI 10.1053/j.ajkd.2018.05.016, PubMed 30122544

Lønning K, Heldal K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisæter AV, Line PD, Hartmann A, Midtvedt K (2018)
Improved Health-Related Quality of Life in Older Kidney Recipients 1 Year After Transplantation
Transplant Direct, 4 (4), e351
DOI 10.1097/TXD.0000000000000770, PubMed 29707622

Lønning K, Midtvedt K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisaeter AV, Line PD, Hartmann A, Heldal K (2018)
Changes in health-related quality of life in older candidates waiting for kidney transplantation
Nephrology (Carlton), 23 (10), 948-956
DOI 10.1111/nep.13117, PubMed 28734131

Majak GB, Reisæter AV, Weedon-Fekjær H, Henriksen T, Michelsen TM (2018)
The Effect of Pregnancy on the Long-term Risk of Graft Loss, Cardiovascular Disease, and Death in Kidney Transplanted Women in Norway: A Retrospective Cohort Study
Transplantation, 102 (9), e391-e396
DOI 10.1097/TP.0000000000002167, PubMed 29528968

Pippias M, Stel VS, Kramer A, Abad Diez JM, Aresté-Fosalba N, Ayav C, Buturovic J, Caskey FJ, Collart F, Couchoud C, De Meester J, Heaf JG, Helanterä I, Hemmelder MH, Kostopoulou M, Noordzij M, Pascual J, Palsson R, Reisaeter AV, Traynor JP, Massy Z, Jager KJ (2018)
Access to kidney transplantation in European adults aged 75-84 years and related outcomes: an analysis of the European Renal Association-European Dialysis and Transplant Association Registry
Transpl Int, 31 (5), 540-553
DOI 10.1111/tri.13125, PubMed 29383764

Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD, Heaf JG, Hemmelder MH, Martínez-Castelao A, de Meester J, Palsson R, Prischl FC, Segelmark M, Traynor JP, Santamaria R, Reisaeter AV, Massy ZA, Jager KJ (2018)
International comparison of trends in patients commencing renal replacement therapy by primary renal disease
Nephrology (Carlton) (in press)
DOI 10.1111/nep.13531, PubMed 30456883

Urstad KH, Wahl AK, Engebretsen E, Larsen MH, Vidnes TK, Stenwig AGK, Simensen ØW, Nordli A, Reisaeter AV, Andersen MH (2018)
Implementation of a new patient education programme for renal transplant recipients
J Ren Care, 44 (2), 106-114
DOI 10.1111/jorc.12236, PubMed 29460501

Publications 2017

Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisæter AV, Mjøen G, Pihlstrøm HK, Næss H, Holdaas H (2017)
Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients
Transplantation, 101 (10), 2599-2605
DOI 10.1097/TP.0000000000001659, PubMed 28207636

Egeland EJ, Robertsen I, Hermann M, Midtvedt K, Størset E, Gustavsen MT, Reisæter AV, Klaasen R, Bergan S, Holdaas H, Hartmann A, Åsberg A (2017)
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation
Transplantation, 101 (8), e273-e279
DOI 10.1097/TP.0000000000001796, PubMed 28452920

Eide IA, Dörje C, Svensson M, Jenssen T, Hammarstrøm C, Scott H, Bjerve KS, Christensen JH, Schmidt EB, Hartmann A, Åsberg A, Reisæter AV, Reinholt FP (2017)
Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid Level
J Ren Nutr, 28 (2), 118-124
DOI 10.1053/j.jrn.2017.09.001, PubMed 29146138

García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV (2017)
Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies
Transplantation, 101 (6), 1410-1415
DOI 10.1097/TP.0000000000001216, PubMed 27163535

Heldal K, Hartmann A, Lønning K, Leivestad T, Reisæter AV, Line PD, Holdaas H, Midtvedt K (2017)
Should patients older than 65 years be offered a second kidney transplant?
BMC Nephrol, 18 (1), 13
DOI 10.1186/s12882-016-0426-0, PubMed 28077080

Koefoed-Nielsen P, Weinreich I, Bengtsson M, Lauronen J, Naper C, Gäbel M, Sørensen SS, Wennberg L, Reisaeter AV, Møller BK, Nordic Kidney group and the Tissue Typing group in Scandiatransplant (2017)
Scandiatransplant acceptable mismatch program (STAMP) a bridge to transplanting highly immunized patients
HLA, 90 (1), 17-24
DOI 10.1111/tan.13046, PubMed 28449350

Lefaucheur C, Viglietti D, Hidalgo LG, Ratner LE, Bagnasco SM, Batal I, Aubert O, Orandi BJ, Oppenheimer F, Bestard O, Rigotti P, Reisaeter AV, Kamar N, Lebranchu Y, Duong Van Huyen JP, Bruneval P, Glotz D, Legendre C, Empana JP, Jouven X, Segev DL, Montgomery RA, Zeevi A, Halloran PF, Loupy A (2017)
Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment
J Am Soc Nephrol, 29 (2), 620-635
DOI 10.1681/ASN.2017050589, PubMed 29042454

Majak GB, Reisæter AV, Zucknick M, Lorentzen B, Vangen S, Henriksen T, Michelsen TM (2017)
Preeclampsia in kidney transplanted women; Outcomes and a simple prognostic risk score system
PLoS One, 12 (3), e0173420
DOI 10.1371/journal.pone.0173420, PubMed 28319175

Midtvedt K, Bergan S, Reisæter AV, Vikse BE, Åsberg A (2017)
Exposure to Mycophenolate and Fatherhood
Transplantation, 101 (7), e214-e217
DOI 10.1097/TP.0000000000001747, PubMed 28346297

Torres IB, Reisaeter AV, Moreso F, Âsberg A, Vidal M, Garcia-Carro C, Midtvedt K, Reinholt FP, Scott H, Castellà E, Salcedo M, Dörje C, Sellarés J, Azancot MA, Perello M, Holdaas H, Serón D (2017)
Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants
Transpl Int, 30 (11), 1119-1131
DOI 10.1111/tri.13002, PubMed 28667664

van den Brand JAJG, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JFM, Jager KJ (2017)
Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry
Nephrol Dial Transplant, 32 (2), 348-355
DOI 10.1093/ndt/gfw392, PubMed 28031344

Publications 2016

Dörje C, Reisaeter AV, Dahle DO, Mjøen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP (2016)
Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant
Clin Transplant, 30 (7), 802-9
DOI 10.1111/ctr.12753, PubMed 27101801

Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisaeter AV, Jenssen T (2016)
Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria
Transpl Int, 29 (5), 568-78
DOI 10.1111/tri.12757, PubMed 26875590

Lønning K, Midtvedt K, Leivestad T, Reisæter AV, Line PD, Hartmann A, Heldal K (2016)
Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
Transplantation, 100 (12), 2705-2709
DOI 10.1097/TP.0000000000001363, PubMed 27861296

Majak GB, Sandven I, Lorentzen B, Vangen S, Reisaeter AV, Henriksen T, Michelsen TM (2016)
Pregnancy outcomes following maternal kidney transplantation: a national cohort study
Acta Obstet Gynecol Scand, 95 (10), 1153-61
DOI 10.1111/aogs.12937, PubMed 27288648

Mjoen G, Reisaeter AV, Dahle DO (2016)
HLA Mismatch and Allograft Survival
Transplantation, 100 (9), e52
DOI 10.1097/TP.0000000000001366, PubMed 27399204

Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2016)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol Dial Transplant, 31 (1), 170
DOI 10.1093/ndt/gfv397, PubMed 26740671

Nordheim E, Dahle DO, Syse IM, Åsberg A, Reisæter AV, Hartmann A (2016)
Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure
Transplant Direct, 2 (11), e113
DOI 10.1097/TXD.0000000000000627, PubMed 27826606

Pippias M, Stel VS, Aresté-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Pálsson R, Ravani P, Segelmark M, Traynor JP, Reisæter AV, Caskey FJ, Jager KJ (2016)
Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry
Transplantation, 100 (9), 1955-62
DOI 10.1097/TP.0000000000000962, PubMed 26588008

Skrunes R, Svarstad E, Reisæter AV, Marti HP, Vikse BE (2016)
End Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population
PLoS One, 11 (11), e0165026
DOI 10.1371/journal.pone.0165026, PubMed 27828975

Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K (2016)
Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience
Nephrology (Carlton), 21 (10), 821-7
DOI 10.1111/nep.12738, PubMed 26854648

Publications 2015

Dörje C, Mjøen G, Strøm EH, Holdaas H, Jenssen T, Øyen O, Akkök ÇA, Cvancarova M, Midtvedt K, Reisaeter AV (2015)
One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
Clin Transplant, 29 (3), 268-76
DOI 10.1111/ctr.12515, PubMed 25644963

Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisæter AV, Jenssen T (2015)
Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus
Transplantation, 99 (3), 629-35
DOI 10.1097/TP.0000000000000376, PubMed 25162478

Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2015)
Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survival
Nephrol Dial Transplant, 31 (1), 160-7
DOI 10.1093/ndt/gfv339, PubMed 26410884

Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2015)
The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation
Clin J Am Soc Nephrol, 10 (7), 1246-56
DOI 10.2215/CJN.11931214, PubMed 26063768

Morken NH, Diaz-Garcia C, Reisaeter AV, Foss A, Leivestad T, Geiran O, Hervás D, Brännström M (2015)
Obstetric and neonatal outcome of pregnancies fathered by males on immunosuppression after solid organ transplantation
Am J Transplant, 15 (6), 1666-73
DOI 10.1111/ajt.13159, PubMed 25868657

Norum J, Leivestad T, Eriksen BO, Skår S, Fagerheim A, Reisæter AV (2015)
Regional differences in renal replacement therapy in northern Norway 2000-2012
Int J Circumpolar Health, 74, 24298
DOI 10.3402/ijch.v74.24298, PubMed 25672881

Norum J, Leivestad T, Eriksen BO, Skår S, Fagerheim A, Reisæter AV (2015)
Regional differences in renal replacement therapy in northern Norway 2000-2012
Int J Circumpolar Health, 74 (1), 24298
DOI 10.3402/ijch.v74.24298, PubMed 28417823

Sriskandarajah S, Aasarød K, Skrede S, Knoop T, Reisæter AV, Bjørneklett R (2015)
Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies
Nephrol Dial Transplant, 30 Suppl 1, i67-75
DOI 10.1093/ndt/gfv008, PubMed 25694535

Waldum-Grevbo B, Leivestad T, Reisæter AV, Os I (2015)
Impact of initial dialysis modality on mortality: a propensity-matched study
BMC Nephrol, 16, 179
DOI 10.1186/s12882-015-0175-5, PubMed 26519164

Publications 2014

Dörje C, Midtvedt K, Reisæter AV (2014)
Analysis of predictive and preventive factors for de novo donor-specific antibodies in kidney transplant recipientsy--is nonadherence of importance?
Transplantation, 98 (4), e31
DOI 10.1097/TP.0000000000000330, PubMed 25243517

Skrunes R, Svarstad E, Reisæter AV, Vikse BE (2014)
Familial clustering of ESRD in the Norwegian population
Clin J Am Soc Nephrol, 9 (10), 1692-700
DOI 10.2215/CJN.01680214, PubMed 25092600

von der Lippe N, Waldum B, Brekke FB, Amro AA, Reisæter AV, Os I (2014)
From dialysis to transplantation: a 5-year longitudinal study on self-reported quality of life
BMC Nephrol, 15, 191
DOI 10.1186/1471-2369-15-191, PubMed 25465066

von der Lippe N, Waldum B, Østhus TB, Reisæter AV, Os I (2014)
Health related quality of life in patients in dialysis after renal graft loss and effect of gender
BMC Womens Health, 14 (1), 34
DOI 10.1186/1472-6874-14-34, PubMed 24580724

Publications 2013

Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vårdal M, Mjøen G, Reisaeter AV, Toft I, Hartmann A (2013)
Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
Clin Transplant, 28 (1), 134-40
DOI 10.1111/ctr.12290, PubMed 24372653

Dörje C, Midtvedt K, Holdaas H, Naper C, Strøm EH, Øyen O, Leivestad T, Aronsen T, Jenssen T, Flaa-Johnsen L, Lindahl JP, Hartmann A, Reisæter AV (2013)
Early versus late acute antibody-mediated rejection in renal transplant recipients
Transplantation, 96 (1), 79-84
DOI 10.1097/TP.0b013e31829434d4, PubMed 23632391

Heldal K, Thorarinsdottir S, Hartmann A, Leivestad T, Reisæter AV, Foss AE, Midtvedt K (2013)
Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
Transplant Res, 2 (1), 11
DOI 10.1186/2047-1440-2-11, PubMed 23799993

Knoop T, Vikse BE, Svarstad E, Leh S, Reisæter AV, Bjørneklett R (2013)
Mortality in patients with IgA nephropathy
Am J Kidney Dis, 62 (5), 883-90
DOI 10.1053/j.ajkd.2013.04.019, PubMed 23796906

Lindahl JP, Hartmann A, Horneland R, Holdaas H, Reisæter AV, Midtvedt K, Leivestad T, Oyen O, Jenssen T (2013)
Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease
Diabetologia, 56 (6), 1364-71
DOI 10.1007/s00125-013-2888-y, PubMed 23549518

Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
Long-term risks for kidney donors
Kidney Int, 86 (1), 162-7
DOI 10.1038/ki.2013.460, PubMed 24284516

Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
Clin Transplant, 28 (1), 120-6
DOI 10.1111/ctr.12288, PubMed 24351078

Åsberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, Thorud LO, Eriksen BO, Hartmann A, NILS Study Group (2013)
Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial
Clin Transplant, 27 (2), E151-6
DOI 10.1111/ctr.12076, PubMed 23351013

Publications 2012

Loftheim H, Midtvedt K, Hartmann A, Reisæter AV, Falck P, Holdaas H, Jenssen T, Reubsaet L, Asberg A (2012)
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
Transplant Res, 1 (1), 9
DOI 10.1186/2047-1440-1-9, PubMed 23369437

Smerud KT, Dolgos S, Olsen IC, Åsberg A, Sagedal S, Reisæter AV, Midtvedt K, Pfeffer P, Ueland T, Godang K, Bollerslev J, Hartmann A (2012)
A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
Am J Transplant, 12 (12), 3316-25
DOI 10.1111/j.1600-6143.2012.04233.x, PubMed 22946930

Temme J, Kramer A, Jager KJ, Lange K, Peters F, Müller GA, Kramar R, Heaf JG, Finne P, Palsson R, Reisæter AV, Hoitsma AJ, Metcalfe W, Postorino M, Zurriaga O, Santos JP, Ravani P, Jarraya F, Verrina E, Dekker FW, Gross O (2012)
Outcomes of male patients with Alport syndrome undergoing renal replacement therapy
Clin J Am Soc Nephrol, 7 (12), 1969-76
DOI 10.2215/CJN.02190312, PubMed 22997344

Vikse BE, Irgens LM, Karumanchi SA, Thadhani R, Reisæter AV, Skjærven R (2012)
Familial factors in the association between preeclampsia and later ESRD
Clin J Am Soc Nephrol, 7 (11), 1819-26
DOI 10.2215/CJN.01820212, PubMed 22956264

Publications 2011

Carrero JJ, de Jager DJ, Verduijn M, Ravani P, De Meester J, Heaf JG, Finne P, Hoitsma AJ, Pascual J, Jarraya F, Reisaeter AV, Collart F, Dekker FW, Jager KJ (2011)
Cardiovascular and noncardiovascular mortality among men and women starting dialysis
Clin J Am Soc Nephrol, 6 (7), 1722-30
DOI 10.2215/CJN.11331210, PubMed 21734088

Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2011)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol Dial Transplant, 27 (1), 443-7
DOI 10.1093/ndt/gfr303, PubMed 21636826

Reisaeter AV, Foss A, Hartmann A, Leivestad T, Midtvedt K (2011)
The kidney transplantation program in Norway since 2000
Clin Transpl, 111-8
PubMed 22755407

Publications 2009

Asberg A, Midtvedt K, Voytovich MH, Line PD, Narverud J, Reisaeter AV, Mørkrid L, Jenssen T, Hartmann A (2009)
Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation
Clin Transplant, 23 (4), 511-8
DOI 10.1111/j.1399-0012.2009.00962.x, PubMed 19210527

Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J (2009)
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation
Transplantation, 88 (3), 429-34
DOI 10.1097/TP.0b013e3181af1f53, PubMed 19667949

Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A (2009)
Experience from an active preemptive kidney transplantation program--809 cases revisited
Transplantation, 88 (5), 672-7
DOI 10.1097/TP.0b013e3181b27b7e, PubMed 19741464

Aasebø W, Midtvedt K, Valderhaug TG, Leivestad T, Hartmann A, Reisaeter AV, Jenssen T, Holdaas H (2009)
Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Nephrol Dial Transplant, 25 (4), 1289-93
DOI 10.1093/ndt/gfp617, PubMed 19934089

Publications 2008

Reisaeter AV, Røislien J, Henriksen T, Irgens LM, Hartmann A (2008)
Pregnancy and birth after kidney donation: the Norwegian experience
Am J Transplant, 9 (4), 820-4
DOI 10.1111/j.1600-6143.2008.02427.x, PubMed 18853953

Tangeraas T, Bjerre A, Lien B, Kyte A, Monn E, Cvancarova M, Leivestad T, Reisaeter AV (2008)
Long-term outcome of pediatric renal transplantation: the Norwegian experience in three eras 1970-2006
Pediatr Transplant, 12 (7), 762-8
DOI 10.1111/j.1399-3046.2007.00896.x, PubMed 18208441

Publications 2007

Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I (2007)
Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes
Transplantation, 83 (5), 600-6
DOI 10.1097/01.tp.0000255583.34329.dd, PubMed 17353781

Publications 2006

Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A (2006)
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients
Transplantation, 82 (1), 62-8
DOI 10.1097/01.tp.0000225803.04995.2b, PubMed 16861943

Bäckman L, Reisaeter AV, Wramner L, Ericzon BG, Salmela K, Brattström C (2006)
Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus
Clin Transplant, 20 (3), 336-9
DOI 10.1111/j.1399-0012.2006.00489.x, PubMed 16824151

Oien CM, Reisaeter AV, Os I, Jardine A, Fellström B, Holdaas H (2006)
Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study
Clin Transplant, 20 (3), 374-82
DOI 10.1111/j.1399-0012.2006.00496.x, PubMed 16824157

Publications 2005

Øien CM, Reisaeter AV, Leivestad T, Pfeffer P, Fauchald P, Os I (2005)
Gender imbalance among donors in living kidney transplantation: the Norwegian experience
Nephrol Dial Transplant, 20 (4), 783-9
DOI 10.1093/ndt/gfh696, PubMed 15701672

Publications 2004

Sund S, Grimm P, Reisaeter AV, Hovig T (2004)
Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis
Nephrol Dial Transplant, 19 (11), 2838-45
DOI 10.1093/ndt/gfh490, PubMed 15385637

Sund S, Reisaeter AV, Scott H, Mollnes TE, Hovig T (2004)
Glomerular monocyte/macrophage influx correlates strongly with complement activation in 1-week protocol kidney allograft biopsies
Clin Nephrol, 62 (2), 121-30
DOI 10.5414/cnp62121, PubMed 15356969

Publications 2003

Sund S, Hovig T, Reisaeter AV, Scott H, Bentdal Ø, Mollnes TE (2003)
Complement activation in early protocol kidney graft biopsies after living-donor transplantation
Transplantation, 75 (8), 1204-13
DOI 10.1097/01.TP.0000062835.30165.2C, PubMed 12717204

Publications 2002

Hartmann A, Jenssen T, Midtvedt K, Reisaeter AV, Fauchald P, Henriksen T, Monn E, Christophersen B (2002)
[Protein-creatinine ratio--a simple method for proteinuria assessment in clinical practice]
Tidsskr Nor Laegeforen, 122 (22), 2180-3
PubMed 12426892

Publications 2001

Reisaeter AV, Hartmann A (2001)
Risk factors and incidence of posttransplant diabetes mellitus
Transplant Proc, 33 (5A Suppl), 8S-18S
DOI 10.1016/S0041-1345(01)02229-1, PubMed 11498199

Publications 1999

Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E (1999)
The role of HLA matching in renal transplantation: experience from one center
Rev Immunogenet, 1 (3), 343-50
PubMed 11256425

Reisaeter AV (1999)
[Kidney transplantation in Norway--a historical perspective]
Tidsskr Nor Laegeforen, 119 (21), 3163-6
PubMed 10522485

Sund S, Reisaeter AV, Fauchald P, Bentdal O, Hall KS, Hovig T (1999)
Living donor kidney transplants: a biopsy study 1 year after transplantation, compared with baseline changes and correlation to kidney function at 1 and 3 years
Nephrol Dial Transplant, 14 (10), 2445-54
DOI 10.1093/ndt/14.10.2445, PubMed 10528671

Publications 1998

Reisaeter AV, Leivestad T, Vartdal F, Spurkland A, Fauchald P, Brekke IB, Thorsby E (1998)
A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients
Transplantation, 66 (4), 523-8
PubMed 9734498

Reisaeter AV, Thorsby E, Brinchmann JE (1998)
Allospecific helper T-lymphocyte repertoire in monozygotic twins
Scand J Immunol, 47 (4), 381-7
PubMed 9600321

Sund S, Reisaeter AV, Scott H, Fauchald P, Bentdal O, Sødal G, Hovig T (1998)
Morphological studies of baseline needle biopsies from living donor kidneys: light microscopic, immunohistochemical and ultrastructural findings
APMIS, 106 (11), 1017-34
DOI 10.1111/j.1699-0463.1998.tb00254.x, PubMed 9890263

Publications 1997

Reisaeter AV, Leivestad T, Fauchald P, Brekke I, Thorsby E (1997)
Influence of matching for HLA-DR in first cadaveric renal transplantation in nonsensitized recipients
Transplant Proc, 29 (7), 3099-100
DOI 10.1016/S0041-1345(97)00798-7, PubMed 9365682

Publications 1996

Reisaeter AV, Brinchmann JE, Lundin KE, Thorsby E (1996)
Monozygotic twins display differences in their allospecific cytotoxic T-cell repertoire
Scand J Immunol, 44 (6), 638-42
DOI 10.1046/j.1365-3083.1996.d01-357.x, PubMed 8972747

Reisaeter AV, Thorsby E, Brinchmann JE (1996)
Analysis of alloreactive helper T lymphocyte precursor frequencies. Influence of interleukin-2 produced by the stimulating cells
J Immunol Methods, 189 (1), 65-72
DOI 10.1016/0022-1759(95)00230-8, PubMed 8576581

Publications 1995

Reisaeter AV, Leivestad T, Albrechtsen D, Holdaas H, Hartmann A, Sødal G, Flatmark A, Fauchald P (1995)
Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients
Transplantation, 60 (3), 242-8
DOI 10.1097/00007890-199508000-00006, PubMed 7645036

Publications 1994

Hartmann A, Lund K, Holdaas H, Fauchald P, Reisaeter A, Berg KJ (1994)
Contrasting short-term effects of nifedipine on glomerular and tubular functions in glomerulonephritic patients
J Am Soc Nephrol, 5 (6), 1385-90
PubMed 7534496

Hartmann A, Reisaeter A, Holdaas H, Rolfsen B, Fauchald P (1994)
Accidental metabolic acidosis during hemodialysis
Artif Organs, 18 (3), 214-7
DOI 10.1111/j.1525-1594.1994.tb02178.x, PubMed 8185487

Reisaeter AV, Fauchald P, Leivestad T, Holdaas H, Hartmann A, Pfeffer P, Sødal G (1994)
Plasma exchange in highly sensitized patients as induction therapy after renal transplantation
Transplant Proc, 26 (3), 1758
PubMed 8030121

Publications 1992

HAUGSTVEDT TK, VISTE A, EIDE GE, MAARTMANNMOE H, MYKING A, SOREIDE O, HANSEN O, ANDENAES K, SKJELDAL S, WESSELHOLST C, SOLHEIM K, OMLAND E, BERGAN A, GERNER T, STADAAS J, HARBITZ TB, LIAVAAG I, HOGNESTAD J, HAVIG O, LEIDAL O, UGGERUD R, NORBYE B, AASEN S, SVANE S, HOLME P et al. (1992)
IS LAUREN HISTOPATHOLOGICAL CLASSIFICATION OF IMPORTANCE IN PATIENTS WITH STOMACH-CANCER - A NATIONAL EXPERIENCE
Eur. J. Surg. Oncol., 18 (2), 124-130

Publications 1990

Dahl O, Horn A, Morild I, Halvorsen JF, Odland G, Reinertsen S, Reisaeter A, Kavli H, Thunold J (1990)
Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway
Cancer, 66 (11), 2286-94
DOI 10.1002/1097-0142(19901201)66:11<2286::AID-CNCR2820661106>3.0.CO;2-T, PubMed 2245382

Page visits: 4514